1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Inflammatory Marker Revenue 1.4 Market Analysis by Type 1.4.1 Global Inflammatory Marker Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Interlukin 1.4.3 C Reactive Protein 1.4.4 Cellular Adhesion Molecule 1.4.5 Tumor Necrosis Factor-α 1.4.6 Others 1.5 Market by Application 1.5.1 Global Inflammatory Marker Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Diagnostic Laboratories 1.5.4 Research Laboratories 1.5.5 Others 1.6 Coronavirus Disease 2019 (Covid-19): Inflammatory Marker Industry Impact 1.6.1 How the Covid-19 is Affecting the Inflammatory Marker Industry 1.6.1.1 Inflammatory Marker Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Inflammatory Marker Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Inflammatory Marker Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Inflammatory Marker Market Perspective (2015-2026) 2.2 Inflammatory Marker Growth Trends by Regions 2.2.1 Inflammatory Marker Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Inflammatory Marker Historic Market Share by Regions (2015-2020) 2.2.3 Inflammatory Marker Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Inflammatory Marker Market Growth Strategy 2.3.6 Primary Interviews with Key Inflammatory Marker Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Inflammatory Marker Players by Market Size 3.1.1 Global Top Inflammatory Marker Players by Revenue (2015-2020) 3.1.2 Global Inflammatory Marker Revenue Market Share by Players (2015-2020) 3.1.3 Global Inflammatory Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Inflammatory Marker Market Concentration Ratio 3.2.1 Global Inflammatory Marker Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Inflammatory Marker Revenue in 2019 3.3 Inflammatory Marker Key Players Head office and Area Served 3.4 Key Players Inflammatory Marker Product Solution and Service 3.5 Date of Enter into Inflammatory Marker Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Inflammatory Marker Historic Market Size by Type (2015-2020) 4.2 Global Inflammatory Marker Forecasted Market Size by Type (2021-2026) 5 Inflammatory Marker Breakdown Data by Application (2015-2026) 5.1 Global Inflammatory Marker Market Size by Application (2015-2020) 5.2 Global Inflammatory Marker Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Inflammatory Marker Market Size (2015-2020) 6.2 Inflammatory Marker Key Players in North America (2019-2020) 6.3 North America Inflammatory Marker Market Size by Type (2015-2020) 6.4 North America Inflammatory Marker Market Size by Application (2015-2020) 7 Europe 7.1 Europe Inflammatory Marker Market Size (2015-2020) 7.2 Inflammatory Marker Key Players in Europe (2019-2020) 7.3 Europe Inflammatory Marker Market Size by Type (2015-2020) 7.4 Europe Inflammatory Marker Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Inflammatory Marker Market Size (2015-2020) 8.2 Inflammatory Marker Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Inflammatory Marker Market Size by Type (2015-2020) 8.4 Asia-Pacific Inflammatory Marker Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 Merck 9.1.1 Merck Company Details 9.1.2 Merck Business Overview and Its Total Revenue 9.1.3 Merck Inflammatory Marker Introduction 9.1.4 Merck Revenue in Inflammatory Marker Business (2015-2020)) 9.1.5 Merck Recent Development 9.2 Novartis 9.2.1 Novartis Company Details 9.2.2 Novartis Business Overview and Its Total Revenue 9.2.3 Novartis Inflammatory Marker Introduction 9.2.4 Novartis Revenue in Inflammatory Marker Business (2015-2020) 9.2.5 Novartis Recent Development 9.3 Thermo Fisher Scientific 9.3.1 Thermo Fisher Scientific Company Details 9.3.2 Thermo Fisher Scientific Business Overview and Its Total Revenue 9.3.3 Thermo Fisher Scientific Inflammatory Marker Introduction 9.3.4 Thermo Fisher Scientific Revenue in Inflammatory Marker Business (2015-2020) 9.3.5 Thermo Fisher Scientific Recent Development 9.4 Cell Signaling Technology 9.4.1 Cell Signaling Technology Company Details 9.4.2 Cell Signaling Technology Business Overview and Its Total Revenue 9.4.3 Cell Signaling Technology Inflammatory Marker Introduction 9.4.4 Cell Signaling Technology Revenue in Inflammatory Marker Business (2015-2020) 9.4.5 Cell Signaling Technology Recent Development 9.5 Boditech Med 9.5.1 Boditech Med Company Details 9.5.2 Boditech Med Business Overview and Its Total Revenue 9.5.3 Boditech Med Inflammatory Marker Introduction 9.5.4 Boditech Med Revenue in Inflammatory Marker Business (2015-2020) 9.5.5 Boditech Med Recent Development 9.6 PHC Holdings 9.6.1 PHC Holdings Company Details 9.6.2 PHC Holdings Business Overview and Its Total Revenue 9.6.3 PHC Holdings Inflammatory Marker Introduction 9.6.4 PHC Holdings Revenue in Inflammatory Marker Business (2015-2020) 9.6.5 PHC Holdings Recent Development 9.7 Abbott 9.7.1 Abbott Company Details 9.7.2 Abbott Business Overview and Its Total Revenue 9.7.3 Abbott Inflammatory Marker Introduction 9.7.4 Abbott Revenue in Inflammatory Marker Business (2015-2020) 9.7.5 Abbott Recent Development 9.8 Siemens 9.8.1 Siemens Company Details 9.8.2 Siemens Business Overview and Its Total Revenue 9.8.3 Siemens Inflammatory Marker Introduction 9.8.4 Siemens Revenue in Inflammatory Marker Business (2015-2020) 9.8.5 Siemens Recent Development 9.9 BG Medicine 9.9.1 BG Medicine Company Details 9.9.2 BG Medicine Business Overview and Its Total Revenue 9.9.3 BG Medicine Inflammatory Marker Introduction 9.9.4 BG Medicine Revenue in Inflammatory Marker Business (2015-2020) 9.9.5 BG Medicine Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Inflammatory Marker Key Market Segments Table 2. Key Players Covered: Ranking by Inflammatory Marker Revenue Table 3. Ranking of Global Top Inflammatory Marker Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Inflammatory Marker Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Interlukin Table 6. Key Players of C Reactive Protein Table 7. Key Players of Cellular Adhesion Molecule Table 8. Key Players of Tumor Necrosis Factor-α Table 9. Key Players of Others Table 10. COVID-19 Impact Global Market: (Four Inflammatory Marker Market Size Forecast Scenarios) Table 11. Opportunities and Trends for Inflammatory Marker Players in the COVID-19 Landscape Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 13. Key Regions/Countries Measures against Covid-19 Impact Table 14. Proposal for Inflammatory Marker Players to Combat Covid-19 Impact Table 15. Global Inflammatory Marker Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 16. Global Inflammatory Marker Market Size by Regions (US$ Million): 2020 VS 2026 Table 17. Global Inflammatory Marker Market Size by Regions (2015-2020) (US$ Million) Table 18. Global Inflammatory Marker Market Share by Regions (2015-2020) Table 19. Global Inflammatory Marker Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 20. Global Inflammatory Marker Market Share by Regions (2021-2026) Table 21. Market Top Trends Table 22. Key Drivers: Impact Analysis Table 23. Key Challenges Table 24. Inflammatory Marker Market Growth Strategy Table 25. Main Points Interviewed from Key Inflammatory Marker Players Table 26. Global Inflammatory Marker Revenue by Players (2015-2020) (Million US$) Table 27. Global Inflammatory Marker Market Share by Players (2015-2020) Table 28. Global Top Inflammatory Marker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Marker as of 2019) Table 29. Global Inflammatory Marker by Players Market Concentration Ratio (CR5 and HHI) Table 30. Key Players Headquarters and Area Served Table 31. Key Players Inflammatory Marker Product Solution and Service Table 32. Date of Enter into Inflammatory Marker Market Table 33. Mergers & Acquisitions, Expansion Plans Table 34. Global Inflammatory Marker Market Size by Type (2015-2020) (Million US$) Table 35. Global Inflammatory Marker Market Size Share by Type (2015-2020) Table 36. Global Inflammatory Marker Revenue Market Share by Type (2021-2026) Table 37. Global Inflammatory Marker Market Size Share by Application (2015-2020) Table 38. Global Inflammatory Marker Market Size by Application (2015-2020) (Million US$) Table 39. Global Inflammatory Marker Market Size Share by Application (2021-2026) Table 40. North America Key Players Inflammatory Marker Revenue (2019-2020) (Million US$) Table 41. North America Key Players Inflammatory Marker Market Share (2019-2020) Table 42. North America Inflammatory Marker Market Size by Type (2015-2020) (Million US$) Table 43. North America Inflammatory Marker Market Share by Type (2015-2020) Table 44. North America Inflammatory Marker Market Size by Application (2015-2020) (Million US$) Table 45. North America Inflammatory Marker Market Share by Application (2015-2020) Table 46. Europe Key Players Inflammatory Marker Revenue (2019-2020) (Million US$) Table 47. Europe Key Players Inflammatory Marker Market Share (2019-2020) Table 48. Europe Inflammatory Marker Market Size by Type (2015-2020) (Million US$) Table 49. Europe Inflammatory Marker Market Share by Type (2015-2020) Table 50. Europe Inflammatory Marker Market Size by Application (2015-2020) (Million US$) Table 51. Europe Inflammatory Marker Market Share by Application (2015-2020) Table 52. Asia-Pacific Key Players Inflammatory Marker Revenue (2019-2020) (Million US$) Table 53. Asia-Pacific Key Players Inflammatory Marker Market Share (2019-2020) Table 54. Asia-Pacific Inflammatory Marker Market Size by Type (2015-2020) (Million US$) Table 55. Asia-Pacific Inflammatory Marker Market Share by Type (2015-2020) Table 56. Asia-Pacific Inflammatory Marker Market Size by Application (2015-2020) (Million US$) Table 57. Asia-Pacific Inflammatory Marker Market Share by Application (2015-2020) Table 58. Merck Company Details Table 59. Merck Business Overview Table 60. Merck Product Table 61. Merck Revenue in Inflammatory Marker Business (2015-2020) (Million US$) Table 62. Merck Recent Development Table 63. Novartis Company Details Table 64. Novartis Business Overview Table 65. Novartis Product Table 66. Novartis Revenue in Inflammatory Marker Business (2015-2020) (Million US$) Table 67. Novartis Recent Development Table 68. Thermo Fisher Scientific Company Details Table 69. Thermo Fisher Scientific Business Overview Table 70. Thermo Fisher Scientific Product Table 71. Thermo Fisher Scientific Revenue in Inflammatory Marker Business (2015-2020) (Million US$) Table 72. Thermo Fisher Scientific Recent Development Table 73. Cell Signaling Technology Company Details Table 74. Cell Signaling Technology Business Overview Table 75. Cell Signaling Technology Product Table 76. Cell Signaling Technology Revenue in Inflammatory Marker Business (2015-2020) (Million US$) Table 77. Cell Signaling Technology Recent Development Table 78. Boditech Med Company Details Table 79. Boditech Med Business Overview Table 80. Boditech Med Product Table 81. Boditech Med Revenue in Inflammatory Marker Business (2015-2020) (Million US$) Table 82. Boditech Med Recent Development Table 83. PHC Holdings Company Details Table 84. PHC Holdings Business Overview Table 85. PHC Holdings Product Table 86. PHC Holdings Revenue in Inflammatory Marker Business (2015-2020) (Million US$) Table 87. PHC Holdings Recent Development Table 88. Abbott Company Details Table 89. Abbott Business Overview Table 90. Abbott Product Table 91. Abbott Revenue in Inflammatory Marker Business (2015-2020) (Million US$) Table 92. Abbott Recent Development Table 93. Siemens Business Overview Table 94. Siemens Product Table 95. Siemens Company Details Table 96. Siemens Revenue in Inflammatory Marker Business (2015-2020) (Million US$) Table 97. Siemens Recent Development Table 98. BG Medicine Company Details Table 99. BG Medicine Business Overview Table 100. BG Medicine Product Table 101. BG Medicine Revenue in Inflammatory Marker Business (2015-2020) (Million US$) Table 102. BG Medicine Recent Development Table 103. Research Programs/Design for This Report Table 104. Key Data Information from Secondary Sources Table 105. Key Data Information from Primary Sources List of Figures Figure 1. Global Inflammatory Marker Market Share by Type: 2020 VS 2026 Figure 2. Interlukin Features Figure 3. C Reactive Protein Features Figure 4. Cellular Adhesion Molecule Features Figure 5. Tumor Necrosis Factor-α Features Figure 6. Others Features Figure 7. Global Inflammatory Marker Market Share by Application: 2020 VS 2026 Figure 8. Hospitals Case Studies Figure 9. Diagnostic Laboratories Case Studies Figure 10. Research Laboratories Case Studies Figure 11. Others Case Studies Figure 12. Inflammatory Marker Report Years Considered Figure 13. Global Inflammatory Marker Market Size YoY Growth 2015-2026 (US$ Million) Figure 14. Global Inflammatory Marker Market Share by Regions: 2020 VS 2026 Figure 15. Global Inflammatory Marker Market Share by Regions (2021-2026) Figure 16. Porter's Five Forces Analysis Figure 17. Global Inflammatory Marker Market Share by Players in 2019 Figure 18. Global Top Inflammatory Marker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Marker as of 2019 Figure 19. The Top 10 and 5 Players Market Share by Inflammatory Marker Revenue in 2019 Figure 20. North America Inflammatory Marker Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Europe Inflammatory Marker Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Asia-Pacific Inflammatory Marker Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 24. Merck Revenue Growth Rate in Inflammatory Marker Business (2015-2020) Figure 25. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. Novartis Revenue Growth Rate in Inflammatory Marker Business (2015-2020) Figure 27. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Thermo Fisher Scientific Revenue Growth Rate in Inflammatory Marker Business (2015-2020) Figure 29. Cell Signaling Technology Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Cell Signaling Technology Revenue Growth Rate in Inflammatory Marker Business (2015-2020) Figure 31. Boditech Med Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Boditech Med Revenue Growth Rate in Inflammatory Marker Business (2015-2020) Figure 33. PHC Holdings Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. PHC Holdings Revenue Growth Rate in Inflammatory Marker Business (2015-2020) Figure 35. Abbott Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Abbott Revenue Growth Rate in Inflammatory Marker Business (2015-2020) Figure 37. Siemens Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Siemens Revenue Growth Rate in Inflammatory Marker Business (2015-2020) Figure 39. BG Medicine Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. BG Medicine Revenue Growth Rate in Inflammatory Marker Business (2015-2020) Figure 41. Bottom-up and Top-down Approaches for This Report Figure 42. Data Triangulation Figure 43. Key Executives Interviewed

Merck Novartis Thermo Fisher Scientific Cell Signaling Technology Boditech Med PHC Holdings Abbott Siemens BG Medicine